Similarly, vaccination with necroptotic cancer cells was found to stimulate the cross-priming of cytotoxic CD8a+ T cells and to produce IFN-g ex vivo, generating a strong anti-tumor response (Aaes et al., 2016). This evidence concerns the gene CD8A and neoplasm.